Accurate quantitation of MHC-bound peptides by application of isotopically labeled peptide MHC complexes

被引:55
作者
Hassan, Chopie [1 ]
Kester, Michel G. D. [2 ]
Oudgenoeg, Gideon [3 ]
de Ru, Arnaud H. [1 ]
Janssen, George M. C. [1 ]
Drijfhout, Jan W. [1 ]
Spaapen, Robbert M. [4 ]
Jimenez, Connie R. [3 ]
Heemskerk, Mirjam H. M. [2 ]
Falkenburg, J. H. Frederik [2 ]
van Veelen, Peter A. [1 ]
机构
[1] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, NL-2300 RC Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Lab Expt Hematol, Dept Hematol, NL-2300 RC Leiden, Netherlands
[3] Vrije Univ Amsterdam, Med Ctr, Dept Med Oncol, OncoProte Lab, Amsterdam, Netherlands
[4] Netherlands Canc Inst NKI AVL, Dept Cell Biol 2, Amsterdam, Netherlands
关键词
Epitopes; hpMHC; MS; Quantitation; SRM; MINOR HISTOCOMPATIBILITY ANTIGENS; STEM-CELL TRANSPLANTATION; RELAPSED LEUKEMIA; REACTIVITY; EPITOPES;
D O I
10.1016/j.jprot.2014.07.009
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Knowledge of the accurate copy number of HLA class I presented ligands is important in fundamental and clinical immunology. Currently, the best copy number determinations are based on mass spectrometry, employing single reaction monitoring (SRM) in combination with a known amount of isotopically labeled peptide. The major drawback of this approach is that the losses during sample pretreatment, i.e. immunopurification and filtration steps, are not well defined and must, therefore, be estimated. In addition, such losses can vary for individual peptides. Therefore, we developed a new approach in which isotopically labeled peptide-MHC monomers (hpMHC) are prepared and added directly after cell lysis, i.e. before the usual sample processing. Using this approach, all losses during sample processing can be accounted for and allows accurate determination of specific MHC class I-presented ligands. Our study pinpoints the immunopurification step as the origin of the rather extreme losses during sample pretreatment and offers a solution to account for these losses. Obviously, this has important implications for accurate HLA-ligand quantitation. The strategy presented here can be used to obtain a reliable view of epitope copy number and thus allows improvement of vaccine design and strategies for immunotherapy. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:240 / 244
页数:5
相关论文
共 14 条
[1]   Kinetics of Antigen Expression and Epitope Presentation during Virus Infection [J].
Croft, Nathan P. ;
Smith, Stewart A. ;
Wong, Yik Chun ;
Tan, Chor Teck ;
Dudek, Nadine L. ;
Flesch, Inge E. A. ;
Lin, Leon C. W. ;
Tscharke, David C. ;
Purcell, Anthony W. .
PLOS PATHOGENS, 2013, 9 (01)
[2]   Graft versus Leukemia Reactivity after Allogeneic Stem Cell Transplantation [J].
Falkenburg, J. H. Frederik ;
Warren, Edus H. .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (01) :S33-S38
[3]   Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS [J].
Gerber, SA ;
Rush, J ;
Stemman, O ;
Kirschner, MW ;
Gygi, SP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (12) :6940-6945
[4]   The Human Leukocyte Antigen-presented Ligandome of B Lymphocytes [J].
Hassan, Chopie ;
Kester, Michel G. D. ;
de Ru, Arnoud H. ;
Hombrink, Pleun ;
Drijfhout, Jan Wouter ;
Nijveen, Harm ;
Leunissen, Jack A. M. ;
Heemskerk, Mirjam H. M. ;
Falkenburg, J. H. Frederik ;
van Veelen, Peter A. .
MOLECULAR & CELLULAR PROTEOMICS, 2013, 12 (07) :1829-1843
[5]   Use of selected reaction monitoring mass spectrometry for the detection of specific MHC class I peptide antigens on A3 supertype family members [J].
Hogan, KT ;
Sutton, JN ;
Chu, KU ;
Busby, JAC ;
Shabanowitz, J ;
Hunt, DF ;
Slingluff, CL .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2005, 54 (04) :359-371
[6]   Discovery of T Cell Epitopes Implementing HLA-Peptidomics into a Reverse Immunology Approach [J].
Hombrink, Pleun ;
Hassan, Chopie ;
Kester, Michel G. D. ;
de Ru, Arnoud H. ;
van Bergen, Cornelis A. M. ;
Nijveen, Harm ;
Drijfhout, Jan W. ;
Falkenburg, J. H. Frederik ;
Heemskerk, Mirjam H. M. ;
van Veelen, Peter A. .
JOURNAL OF IMMUNOLOGY, 2013, 190 (08) :3869-3877
[7]   Immune self-reactivity triggered by drug-modified HLA-peptide repertoire [J].
Illing, Patricia T. ;
Vivian, Julian P. ;
Dudek, Nadine L. ;
Kostenko, Lyudmila ;
Chen, Zhenjun ;
Bharadwaj, Mandvi ;
Miles, John J. ;
Kjer-Nielsen, Lars ;
Gras, Stephanie ;
Williamson, Nicholas A. ;
Burrows, Scott R. ;
Purcell, Anthony W. ;
Rossjohn, Jamie ;
McCluskey, James .
NATURE, 2012, 486 (7404) :554-U158
[8]   Vaccination against HPV-16 Oncoproteins for Vulvar Intraepithelial Neoplasia. [J].
Kenter, Gemma G. ;
Welters, Marij J. P. ;
Valentijn, A. Rob P. M. ;
Lowik, Margriet J. G. ;
Berends-van der Meer, Dorien M. A. ;
Vloon, Annelies P. G. ;
Essahsah, Farah ;
Fathers, Lorraine M. ;
Offringa, Rienk ;
Drijfhout, Jan Wouter ;
Wafelman, Amon R. ;
Oostendorp, Jaap ;
Fleuren, Gert Jan ;
van der Burg, Sjoerd H. ;
Melief, Cornelis J. M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (19) :1838-1847
[9]   Generation and administration of HA-1-specific T-cell lines for the treatment of patients with relapsed leukemia after allogeneic stem cell transplantation: a pilot study [J].
Meij, Pauline ;
Jedema, Inge ;
van der Hoorn, Menno A. W. G. ;
Bongaerts, Rian ;
Cox, Linda ;
Wafelman, Amon R. ;
Marijt, Erik W. A. ;
Willemze, Roel ;
Falkenburg, J. H. Frederik .
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2012, 97 (08) :1205-1208
[10]   NCI First International Workshop on The Biology, Prevention, and Treatment of Relapse After Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on the Biology Underlying Recurrence of Malignant Disease following Allogeneic HSCT: Graft-versus-Tumor/Leukemia Reaction [J].
Miller, Jeffrey S. ;
Warren, Edus H. ;
van den Brink, Marcel R. M. ;
Ritz, Jerome ;
Shlomchik, Warren D. ;
Murphy, William J. ;
Barrett, A. John ;
Kolb, Hans Jochem ;
Giralt, Sergio ;
Bishop, Michael R. ;
Blazar, Bruce R. ;
Falkenburg, J. H. Frederik .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (05) :565-586